puntobancobaccarat| Jingfeng Pharmaceutical led the gains: CITIC Pharmaceutical Biotech fell 2.0% this week

News summary

CITIC Pharmaceutical Biotech Sector performed weakly this weekpuntobancobaccarat, overall decline of 2puntobancobaccarat.0%puntobancobaccarat, lagging behind the Shanghai and Shenzhen 300 Index by 2puntobancobaccarat.3 percentage points. Year-to-date, the sector has fallen 8.9%, ranking 25th. Among individual stocks, Jingfeng Pharmaceutical took the lead this week, reaching 17.61%.

Newsletter text

[CITIC Pharmaceutical Biotech fell 2.0% this week, underperforming the Shanghai and Shenzhen 300 Index]

This week (5.13-5.17), the CITIC Pharmaceutical Biosector Index experienced a decline of 2.0%, lagging behind by 2.3 percentage points compared with the Shanghai and Shenzhen 300 Index, ranking 29th in CITIC's industry classification.

Since the beginning of the year, the sector's index has fallen by 8.9%, lagging behind the Shanghai and Shenzhen 300 Index by 16.1 percentage points, ranking 25th in CITIC's industry classification.

In this week's performance of individual stocks, Jingfeng Pharmaceutical ranked among the top five with an increase of 17.61%, while the performance of ST Jiao 'ang and other companies is also worthy of attention.

Tags:

Prev: spicycasinonodeposit| China Securities Regulatory Commission Chairman Wu Qing meets with Saudi Finance Minister Jedan (photo)
Next: poppyplaytimechapter2crash| BAHEAL Pharmaceutical acquires 60% equity in BAHEAL Pharmaceutical for 880 million yuan